Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

Iloprost, a stable prostacyclin analogue, was given by intravenous infusion to 29 patients with severe Raynaud's phenomenon, 26 of whom had systemic sclerosis (SS), and compared with placebo infusion in a double blind crossover trial. Iloprost significantly lessened the number and the severity of at...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Ann Rheum Dis
Principais autores:	McHugh, N J, Csuka, M, Watson, H, Belcher, G, Amadi, A, Ring, E F, Black, C M, Maddison, P J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003442/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2449871/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.47.1.43
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!